EIS Eczacibasi Ilac stock posts a TRY 760.505 million loss

EIS Eczacibasi Ilac (ISIN TRAECILC91E0) reported revenue of TRY 2.238777 billion and a net loss of TRY 760.505 million in its latest reported quarter. The figures underline the pressure on the Turkish investment and industrial holding company as its revenue declined from TRY 2.940203 billion in the previous quarter.

Quarterly revenue fell 23.856 percent

Investing.com Canada reports that the latest quarter produced TRY 2.238777 billion in sales, compared with TRY 2.940203 billion in the previous quarter. The same report lists net income of negative TRY 760.505 million, against negative TRY 1.094345 billion previously.

The quarterly EPS figure was negative TRY 1.110, while the revenue comparison shows a 23.856 percent sequential decline. For investors, the combination of lower sales and another quarterly loss makes operating performance more important than the holding company label alone.

Merger plan adds a corporate checkpoint

On September 24, 2026, KAP published EIS Eczacibasi Ilac's application to the Capital Markets Board for a simplified merger with its wholly owned subsidiary Eczacibasi Gayrimenkul. The transaction uses financial statements dated June 30, 2026, and the disclosure states that no capital increase is planned.

The merger therefore changes the corporate structure rather than adding new shares. The disclosure assigns the transaction to ECILC and shows paid-in capital of TRY 685.260 million, giving investors a concrete reference point for the planned simplification.

Market value remains below yearly high

EIS Eczacibasi Ilac had a market capitalization of TRY 42.5 billion on October 7, 2026. Its 52-week range was TRY 54.80 to TRY 132.60, while trading volume reached 2,530,506 shares on the same date.

The range places the lower end TRY 77.80 below the yearly high, a gap of 58.67 percent based on the quoted levels. That spread and the latest quarterly loss leave the next reported operating update as the key fundamental checkpoint for the stock.

Market capitalization and listing

EIS Eczacibasi Ilac was last quoted at TRY 61.95 on October 7, 2026, with Borsa Istanbul as its primary venue. The company operates across pharmaceuticals, industrial activities and financial investments, and its ECILC listing is identified on Borsa Istanbul under ISIN TRAECILC91E0.

More news and analyses on EIS Eczacibasi Ilac stock